大研医器（7775） – (Delayed)Summary of Non-Consolidated Financial Results for the Year Ended March 31, 2022

Notice: This document is an excerpt translation of the original Japanese document and is only for reference purposes. In the event of any Translation discrepancy between this translated document and the original Japanese document, the latter shall prevail. Summary of Non-Consolidated Financial Results for the Year Ended March 31, 2022 (Based on Japanese GAAP) Company name: DAIKEN MEDICAL CO., LTD. Stock exchange listing: Tokyo Stock code: 7775 URL https://daiken-iki.co.jp Representative: Inquiries: President General Manager Finance and Accounting Keiichi Yamada Toshikazu Itami TEL 0725-30-3574 Division Scheduled date of ordinary general meeting of shareholders: Scheduled date to file Securities Report: Scheduled date to commence dividend payments: June 21, 2022 June 21, 2022 June 6, 2022 May 13, 2022Preparation of supplementary material on financial results: Holding of financial results meeting: 1. Non-consolidated financial results for the year ended March 31, 2022 (from April 1, 2021 to March 31, 2022) Yes No (Amounts less than one million yen are rounded down)(1) Non-consolidated operating results Percentages indicate year-on-year changesYear ended March 31, 2022 Year ended March 31, 2021 Net sales Operating profit Ordinary profit Profit Millions of yen 8,540 7,861 % Millions of yen 1,150 8.6 921 (7.8)% Millions of yen 1,152 957 24.9 (22.9)% Millions of yen 831 675 20.4 (20.9) % 23.1 (21.4)Year ended March 31, 2022 Year ended March 31, 2021 (2) Non-consolidated financial position As of March 31, 2022 As of March 31, 2021 (3) Non-consolidated cash flows Year ended March 31, 2022 Year ended March 31, 2021 2. Cash dividends Year ended March 31, 2021 Year ended March 31, 2022 Year ending March 31, 2023 (Forecast) Earnings per share Diluted earnings per share Profit/equity Ordinary profit/total assets Operating profit/net sales Yen 28.93 23.50 Yen – – % 13.2 11.0 % 10.6 8.8 Total assets Net assets Equity ratio Net assets per share Millions of yen 10,920 10,752 Millions of yen 6,446 6,182 % 59.0 57.5 Cash flows from operating activities Cash flows from investing activities Cash flows from financing activities Cash and cash equivalents at end of period Millions of yen 1,133 609 Millions of yen (196)(311)Millions of yen (589)(492)Millions of yen 2,518 2,170 % 13.5 11.7 Yen 224.13 215.20 Annual dividends per share 1st quarter-end 2nd quarter-end 3rd quarter-end Fiscal year-end Total Total cash dividends (Total) Dividend payout ratio (Non-consolidated) Ratio of dividends to net assets (Non-consolidated) Yen – – – Yen 9.00 9.00 9.00 Yen – – – Yen 11.00 11.00 11.00 Yen Millions of yen 20.00 20.00 20.00 574 574 % 85.1 69.1 68.4 % 9.4 9.1 13. Forecast of non-consolidated financial results for the year ending March 31, 2023 (from April 1, 2022 to March 31, 2023) Percentages indicate year-on-year changesNet sales Operating profit Ordinary profit Profit Earnings per share Millions of yen % Millions of yen % Millions of yen % Millions of yen % 4,170 8,750 2.1 2.5 520 (8.0)520 (8.0)1,200 4.3 1,200 4.1 360 (10.1)840 1.1 Yen 12.53 29.24 Six months ending September 30, 2022 Full year 4. Notes (1) Changes in accounting policies, changes in accounting estimates, and restatement of prior period financial statements Changes in accounting policies due to revisions to accounting standards and other regulations: Changes in accounting policies due to other reasons: Changes in accounting estimates: Restatement of prior period financial statements: (2) Number of issued shares (common shares) Total number of issued shares at the end of the period (including treasury shares) Yes No No No As of March 31, 2022 31,840,000 shares As of March 31, 2021 31,840,000 shares Number of treasury shares at the end of the period Average number of shares during the period As of March 31, 2022 3,111,559 shares As of March 31, 2021 3,111,559 shares Year ended March 31, 2022 28,728,441 shares Year ended March 31, 2021 28,728,441 shares 2 As of March 31, 2021 As of March 31, 2022 (Thousands of yen) Non-consolidated financial statements Non-consolidated balance sheets Assets Current assets Cash and deposits Notes receivable – trade Electronically recorded monetary claims – operating Accounts receivable – trade 6,272,550 6,572,435 2,170,643 207,599 989,922 1,390,157 891,412 86,665 443,833 23,090 69,312 (87) 2,019,367 1,744 183,881 32 240,247 1,703,670 36,804 39,343 4,225,091 16,620 – 5,103 21,723 10 2,954 166,802 53,391 13,100 8,797 13,150 (24,650) 233,555 2,518,589 130,420 1,085,208 1,215,746 973,067 72,279 499,189 19,796 58,227 (91) 1,937,619 1,382 151,205 0 161,062 1,703,670 33,557 130,902 4,119,400 9,604 427 5,103 15,135 10 2,128 160,449 40,846 13,100 8,797 13,150 (24,650) 213,831 4,480,370 10,752,921 4,348,367 10,920,803 Finished goods Work in process Raw materials Prepaid expenses Other Allowance for doubtful accounts Total current assets Non-current assets Property, plant and equipment Buildings, net Structures, net Machinery and equipment, net Vehicles, net Tools, furniture and fixtures, net Land Leased assets, net Construction in progress Total property, plant and equipment Intangible assets Software Software in progress Telephone subscription right Total intangible assets Investments and other assets Investments in capital Long-term prepaid expenses Deferred tax assets Guarantee deposits Membership Life insurance funds Long-term accounts receivable – other Allowance for doubtful accounts Total investments and other assets Total non-current assets Total assets 3 As of March 31, 2021 As of March 31, 2022 (Thousands of yen) 405,109 141,364 411,252 1,000,000 704,034 140,220 11,875 179,500 111,074 8,089 12,178 32,826 561 179,346 6,738 2,844 3,347,018 1,177,859 28,894 14,085 2,789 1,223,627 4,570,645 495,875 400,875 400,875 23,750 690,000 6,398,357 7,112,107 (1,826,582) 6,182,275 – 6,182,275 10,752,921 13,336 546,724 443,847 1,000,000 597,826 138,601 11,194 70,899 212,541 76,182 11,348 5,967 13,744 – – 9,022 3,151,237 1,280,033 26,142 14,604 2,654 1,323,434 4,474,671 495,875 400,875 400,875 23,750 690,000 6,654,845 7,368,595 (1,826,582) 6,438,763 7,368 6,446,131 10,920,803 Liabilities Current liabilities Notes payable – trade Electronically recorded obligations – operating Accounts payable – trade Short-term borrowings Current portion of long-term borrowings Accounts payable – other Lease liabilities Accrued expenses Income taxes payable Accrued consumption taxes Deposits received Notes payable – facilities Electronically recorded obligations-facilities Provision for Sales allowance Asset retirement obligations Other Total current liabilities Non-current liabilities Long-term borrowings Lease liabilities Long-term guarantee deposits Other Total non-current liabilities Total liabilities Net assets Shareholders’ equity Share capital Capital surplus Legal capital surplus Total capital surplus Retained earnings Legal retained earnings Other retained earnings General reserve Total retained earnings Treasury shares Total shareholders’ equity Share acquisition rights Total net assets Total liabilities and net assets Retained earnings brought forward 4Non-consolidated statements of income Net sales Cost of sales Beginning finished goods inventory Cost of products manufactured Cost of purchased goods Cost of construction by the outside order Total Transfer to other account Ending finished goods inventory Selling, general and administrative expenses Total cost of sales Gross profit Operating profit Non-operating income Interest income Compensation income Foreign exchange gains Gain on forfeiture of unclaimed dividends Subsidy income Miscellaneous income Total non-operating income Non-operating expenses Interest expenses Other Total non-operating expenses Ordinary profit Extraordinary losses Office transfer related cost Total extraordinary losses Profit before income taxes Income taxes – current Income taxes – deferred Total income taxes Profit Loss on retirement of non-current assets (Thousands of yen) Fiscal year ended March 31, 2021 Fiscal year ended March 31, 2022 7,861,969 770,451 4,684,874 27,796 7,736 5,490,859 96,612 891,412 4,502,833 3,359,135 2,437,919 921,216 0 843 704 1,059 36,072 1,142 39,822 3,807 6 3,813 957,225 707 11,767 12,474 944,750 241,502 28,016 269,518 675,231 8,540,443 891,412 4,941,661 85,882 8,399 5,927,356 97,806 973,067 4,856,482 3,683,960 2,533,081 1,150,878 0 1,537 1,164 796 – 1,738 5,236 3,737 3 3,740 1,037 – 1,037 1,152,374 1,151,337 313,928 6,352 320,280 831,056 5Non-consolidated statements of changes in equity Fiscal year ended March 31, 2021 (Thousands of yen) Shareholders’ equity Capital surplus Share capital Legal capital surplus Total capital surplus Legal retained earnings Total retained earnings Retained earnings Other retained earnings General reserve Retained earnings brought forward (574,568) (574,568) 675,231 675,231 Balance at beginning of period 495,875 400,875 400,875 23,750 690,000 6,297,694 7,011,444 Changes during period Dividends of surplus Profit Net changes in items other than shareholders’ equity Total changes during period – – – – – 100,663 100,663 Balance at end of period 495,875 400,875 400,875 23,750 690,000 6,398,357 7,112,107 Shareholders’ equity Treasury shares Total shareholders’ equity Share acquisition rights Total net assets Balance at beginning of period (1,826,582) 6,081,612 – 6,081,612 Changes during period Dividends of surplus Profit Net changes in items other than shareholders’ equity (574,568) 675,231 (574,568) 675,231 – Total changes during period – 100,663 Balance at end of period (1,826,582) 6,182,275 – – 100,663 6,182,275 6 Fiscal year ended March 31, 2022 Changes during period Dividends of surplus Profit Net changes in items other than shareholders’ equity Shareholders’ equity Capital surplus (Thousands of yen) Share capital Legal capital surplus Total capital surplus Legal retained earnings Total retained earnings Retained earnings Other retained earnings General reserve Retained earnings brought forward (574,568) (574,568) 831,056 831,056 Balance at beginning of period 495,875 400,875 400,875 23,750 690,000 6,398,357 7,112,107 Total changes during period – – – – – 256,487 256,487 Balance at end of period 495,875 400,875 400,875 23,750 690,000 6,654,845 7,368,595 Shareholders’ equity Treasury shares Total shareholders’ equity Share acquisition rights Total net assets Balance at beginning of period (1,826,582) 6,182,275 – 6,182,275 Changes during period Dividends of surplus Profit Net changes in items other than shareholders’ equity Total changes during period – 256,487 Balance at end of period (1,826,582) 6,438,763 (574,568) 831,056 (574,568) 831,056 7,368 263,856 6,446,131 7,368 7,368 7,368 7 (Thousands of yen) Fiscal year ended March 31, 2021 Fiscal year ended March 31, 2022 944,750 256,517 – (5) 179,346 (0) 3,807 138,703 (248,458) (8,740) 11,767 707 (36,072) 31,808 7,389 (266,186) (82,700) 6,228 938,862 0 (3,692) (325,998) 609,170 (308,098) – (3,949) (733) 874 – (311,906) 800,000 (908,031) (574,884) 200,000 (9,105) (492,021) (194,757) 2,365,400 2,170,643 1,151,337 314,423 7,368 4 (179,346) (0) 3,737 156,304 (122,625) 46,181 – 1,037 – 1,401 (8,701) (108,601) 68,092 25,499 1,356,112 0 (3,989) (218,500) 1,133,623 (202,502) 912 (714) (480) 13,026 (6,479) (196,237) 700,000 (704,034) (574,296) – (11,108) (589,439) 347,946 2,170,643 2,518,589 Non-consolidated statements of cash flows Cash flows from operating activities Profit before income taxes Depreciation Share-based payment expenses Increase (decrease) in allowance for doubtful accounts Increase (decrease) in provision for sales allowance Interest and dividend income Interest expenses Decrease (increase) in trade receivables Decrease (increase) in inventories Increase (decrease) in trade payables Office transfer related cost Loss on retirement of non-current assets Subsidy income Decrease (increase) in accounts receivable – other Increase (decrease) in accounts payable – other Increase (decrease) in accrued expenses Increase/decrease in consumption taxes payable/consumption taxes refund receivable Other, net Subtotal Interest and dividends received Interest paid Income taxes paid Net cash provided by (used in) operating activities Cash flows from investing activities Purchase of property, plant and equipment Proceeds from sale of property, plant and equipment Purchase of intangible assets Payments of guarantee deposits Proceeds from refund of guarantee deposits Payments for asset retirement obligations Net cash provided by (used in) investing activities Cash flows from financing activities Proceeds from long-term borrowings Repayments of long-term borrowings Dividends paid Net increase (decrease) in short-term borrowings Repayments of lease liabilities Net cash provided by (used in) financing activities Net increase (decrease) in cash and cash equivalents Cash and cash equivalents at beginning of period Cash and cash equivalents at end of period 8